Rad Source was founded in 1997 for the purpose of creating non-gamma irradiation alternatives. Even prior to the more recent security issues associated with radioactive gamma sources, Kirk’s vision was to solve environmental disposal and related practical issues associated with “hot” source equipment. Based on that, we introduced our first products in 1999 incorporating X-ray technology including the first FDA cleared X-ray blood irradiator as well as our laboratory research X-ray irradiator, the RS 2000.

Since then, we’ve continued expanding our capabilities and adding to our proprietary X-ray based irradiation technology, developing proprietary x-ray sources and new equipment.

X-RAY IRRADIATION TECHNOLOGY

The RS 3400 Blood Irradiator

THE PREMIER X-RAY BLOOD IRRADIATOR IN THE WORLD PROVIDING SUPERIOR UNIFORMITY AND INDUSTRY LEADING RELIABILITY.

Blood transfusion is a lifesaving procedure for people who are bleeding and people who cannot make a sufficient amount of blood on their own. A rare but almost always fatal complication from blood transfusion is called transfusion-associated graft-versus-host disease (TA-GVHD), where immune cells from the donor blood attach the recipient’s organs and cause a deadly infection that is nearly impossible to fight off.

Over 20 years ago, we pioneered the first-ever FDA-approved blood x-ray irradiation medical device used to prevent TA-GVHD, and we have maintained our status as the industry leader and gold-standard in blood irradiation technology and instrumentation ever since. Our patented x-ray irradiation technology effectively and routinely inactivates the immune cells in donor blood, which diminishes the risk of developing TA-GVHD for the transfusion recipient.

The RS 1800 Q Biological Irradiator

THE MOST POWERFUL DEDICATED CELL IRRADIATOR AVAILABLE

Cancer researchers utilize our patented x-ray irradiation technology to assess the effects of radiation on different types of cancer cells in laboratory experiments, enabling them to more accurately predict the outcomes of radiation therapy in cancer patients.

Cancer cells are normal cells that have suffered genetic mutations in their DNA that cause them to multiply uncontrollably and escape death. Cancer cells display several “hallmark” behaviors that are characteristic of cells from all types of cancer, but individual types of cancer differ greatly in other behaviors, particularly in their response to radiation.

It is critical for cancer researchers to evaluate the effects of radiation on cancer cell in the laboratory because this will lead to safer and more effective treatments for human cancer patients undergoing radiation therapy in the hospital or clinic.

Our patented x-ray irradiation technology is the preferred method to stimulate radiation therapy in the laboratory, enabling cancer researchers to perform experiments that show how cancer cells gain resistance to radiation and other experiments that evaluate the collective effect of new drugs or doses in combination with radiation therapy.